1998
DOI: 10.1111/j.1440-1673.1998.tb00504.x
|View full text |Cite
|
Sign up to set email alerts
|

Spontaneous arterial thrombosis in association with pancreatic carcinoma: Diagnosis and interventional management

Abstract: A 58-year-old woman presented with bilateral upper limb ischaemia. Digital subtraction angiography demonstrated upper limb arterial thrombosis, extensive on the left. This was initially treated with catheter-directed thrombolysis which cleared the thrombus on the right, although the left upper limb required supplementary surgical embolectomy. Subsequently, biopsy-proven pancreatic adenocarcinoma was detected. The upper limb arterial thrombosis appeared to be spontaneous in association with the malignancy becau… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Lower-extremity deep venous thrombosis, thrombophlebitis migrans, and pulmonary embolism are among the well-known presentations in pancreatic cancer. Further manifestations also include disseminated intravascular coagulation, splenic vein thrombosis, portal or superior mesenteric vein thrombosis, and spontaneous arterial thromboembolism, extremity ischemia, and mesenteric or iliofemoral occlusion [ 4 - 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Lower-extremity deep venous thrombosis, thrombophlebitis migrans, and pulmonary embolism are among the well-known presentations in pancreatic cancer. Further manifestations also include disseminated intravascular coagulation, splenic vein thrombosis, portal or superior mesenteric vein thrombosis, and spontaneous arterial thromboembolism, extremity ischemia, and mesenteric or iliofemoral occlusion [ 4 - 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…[8][9][10][11] Cancer therapy (surgery, chemotherapy, and hormonal therapy) serves as an additional risk factor for developing VTE. According to a retrospective analysis of the Prophylaxis of Thromboembolism During Chemotherapy (PROTECHT) study, 12 in the absence of thrombophylaxis, the highest risk of thrombosis is seen in patients receiving gemcitabine (8.1%) or cisplatin-based chemotherapy (7%).…”
mentioning
confidence: 99%